Metabolic Research Laboratory, Clínica Universidad de Navarra, Avda. Pío XII, 36, 31008, Pamplona, Spain.
CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Pamplona, Spain.
J Physiol Biochem. 2024 Feb;80(1):149-160. doi: 10.1007/s13105-023-00993-x. Epub 2023 Nov 7.
Bariatric surgery has become a recognized and effective procedure for treating obesity and type 2 diabetes (T2D). Our objective was to directly compare the caloric intake-independent effects of sleeve gastrectomy (SG) and single anastomosis duodenoileal bypass with SG (SADI-S) on glucose tolerance in rats with diet-induced obesity (DIO) and to elucidate the differences between bariatric surgery and caloric restriction.A total of 120 adult male Wistar rats with DIO and insulin resistance were randomly assigned to surgical (sham operation, SG, and SADI-S) and dietary (pair-feeding the amount of food eaten by animals undergoing the SG or SADI-S surgeries) interventions. Body weight and food intake were weekly monitored, and 6 weeks after interventions, fasting plasma glucose, oral glucose and insulin tolerance tests, plasma insulin, adiponectin, GIP, GLP-1, and ghrelin levels were determined.The body weight of SADI-S rats was significantly (p < 0.001) lower as compared to the sham-operated, SG, and pair-fed groups. Furthermore, SADI-S rats exhibited decreased whole body fat mass (p < 0.001), lower food efficiency rates (p < 0.001), and increased insulin sensitivity, as well as improved glucose and lipid metabolism compared to that of the SG and pair-fed rats.SADI-S was more effective than SG, or caloric restriction, in improving glycemic control and metabolic profile, with a higher remission of insulin resistance as well as long-term weight loss.
减重手术已成为治疗肥胖症和 2 型糖尿病(T2D)的公认有效方法。我们的目的是直接比较袖状胃切除术(SG)和单吻合口十二指肠空肠旁路术与 SG(SADI-S)对饮食诱导肥胖(DIO)大鼠葡萄糖耐量的热量摄入无关影响,并阐明减重手术与热量限制之间的差异。
共有 120 只患有 DIO 和胰岛素抵抗的成年雄性 Wistar 大鼠被随机分为手术(假手术、SG 和 SADI-S)和饮食(根据 SG 或 SADI-S 手术动物的进食量进行配对喂养)干预组。每周监测体重和食物摄入量,干预 6 周后,测定空腹血糖、口服葡萄糖和胰岛素耐量试验、血浆胰岛素、脂联素、GIP、GLP-1 和 ghrelin 水平。
与假手术组、SG 组和配对喂养组相比,SADI-S 大鼠的体重显著(p < 0.001)降低。此外,SADI-S 大鼠表现出全身脂肪量减少(p < 0.001)、食物效率降低(p < 0.001)、胰岛素敏感性增加以及葡萄糖和脂质代谢改善,与 SG 和配对喂养大鼠相比。
SADI-S 在改善血糖控制和代谢谱方面比 SG 或热量限制更有效,具有更高的胰岛素抵抗缓解率和长期体重减轻。